Recent News

• 09.05.2025 - DiaMedica Therapeutics to Participate in Upcoming Investor Conferences
• 09.02.2025 - DiaMedica Therapeutics to Participate in Cantor Global Healthcare Conference
• 08.12.2025 - DiaMedica Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights
• 08.06.2025 - DiaMedica Therapeutics Appoints Julie Krop, MD, as Chief Medical Officer
• 08.05.2025 - DiaMedica Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update August 13, 2025

Recent Filings

• 09.04.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 09.04.2025 - 4 Statement of changes in beneficial ownership of securities
• 08.27.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 08.22.2025 - 424B2 Prospectus [Rule 424(b)(2)]
• 08.22.2025 - EFFECT Notice of Effectiveness
• 08.12.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 08.12.2025 - 8-K Current report
• 08.12.2025 - EX-99.1 EX-99.1
• 08.12.2025 - S-3 Registration statement under Securities Act of 1933
• 08.12.2025 - 8-K Current report